Global Anti-viral Drugs Market Worth USD 42.3 Billion By 2024 | Growth Rate CAGR of 5.9% Markets & Research - PowerPoint PPT Presentation

Loading...

PPT – Global Anti-viral Drugs Market Worth USD 42.3 Billion By 2024 | Growth Rate CAGR of 5.9% Markets & Research PowerPoint presentation | free to download - id: 882435-OWMyZ



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Anti-viral Drugs Market Worth USD 42.3 Billion By 2024 | Growth Rate CAGR of 5.9% Markets & Research

Description:

Anti-Viral Drug Market By Application (HIV Treatment, Hepatitis Treatment, Herpes Treatment, Influenza Treatment, Others) By Type (Generic Drugs, Branded Drugs) By End User (Hospitals, Clinics, Others) and Region - Global Forecast 2016 to 2024. – PowerPoint PPT presentation

Number of Views:15
Slides: 11
Provided by: DenMark1
Category: Other

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Anti-viral Drugs Market Worth USD 42.3 Billion By 2024 | Growth Rate CAGR of 5.9% Markets & Research


1
Global Anti-Viral Drug Market Outlook Industry
Insights Opportunity Evaluation, 2017-2024
2
Global Anti-Viral Drug Market Overview Anti-Vira
l Drug Market By Application (HIV Treatment,
Hepatitis Treatment, Herpes Treatment, Influenza
Treatment, Others) By Type (Generic Drugs,
Branded Drugs) By End User (Hospitals, Clinics,
Others) and Region - Global Forecast 2016 to
2024. Anti-viral drugs refer to the class of
antimicrobials which are used specifically for
the treatment of viral infections. Anti-viral
drugs are formulated to treat HIV, hepatitis
virus, influenza and herpes virus. These
anti-viral drugs can be used only for specific
disease. Market Size and Forecast Global
Anti-Viral Drug Market is anticipated to flourish
at a CAGR of 5.9 over the forecast period.
Further, the market of anti-viral drugs accounted
for USD 31.2 Billion in 2016 and is projected to
garner USD 42.3 by the end of 2024. Rising
prevalence of viral infections and diseases
across the globe is expected to increase the
demand for anti-viral drugs globally. In the
regional platform, North America dominated the
overall market of anti-viral drugs in 2016.
Further, North America market is expected to
continue its dominance over the forecast period
on the account of rising healthcare expenditure.
Additionally, presence of highly developed
healthcare infrastructure and rising awareness
about the viral infections is expected to fuel
the growth of Anti-Viral Drug Market in the North
America region. U.S. is expected to be the major
contributor to the growth of anti-viral drugs
owing to the presence of major key players. Asia
Pacific is anticipated to witness robust growth
over the forecast period 2017-2024. This growth
can be attributed to the increasing number of
virus infected people and rising disposable
income of the population.
3
  • Additionally, rising medical tourism in the
    region is projected to supplement the growth of
    the anti-viral drugs market. Developing economies
    such as China, India are the major countries
    witnessing the augmented demand for anti-viral
    drugs. Further, favorable government regulations
    boosting the growth of healthcare sector in the
    region is likely to swell the demand for
    anti-viral drugs.
  • Middle East Africa anti-viral drugs market is
    expected to grow at a significant pace during the
    forecast period. In 2016, 25.6 Million people
    were estimated to be living with HIV. This factor
    is anticipated to trigger the growth of
    anti-viral drugs market in Middle East Africa
    region. The demand for anti-viral drugs in Latin
    America is forecasted to increase in the upcoming
    years. High number of deaths caused from viral
    diseases is predicted to garner the growth of
    anti-viral drugs in the Latin America region.
  • On the basis of type, anti-viral drug market is
    further segmented into generic drugs and branded
    drugs. Generic drugs accounted for the largest
    percentage of market share in overall anti-viral
    drug market. Further, this segment is anticipated
    to witness highest CAGR during the forecast
    period.
  • Market Segmentation
  • Our in-depth analysis has segmented global
    anti-viral drug market into the following
    segments
  • By Type
  • Generic Drugs
  • Branded Drugs
  • By Application
  • HIV Treatment
  • Hepatitis Treatment
  • Herpes Treatment
  • Influenza Treatment

4
  • By End User
  • Hospitals
  • Clinics
  • Others
  • By Region
  • Global anti-viral drug market is further
    classified on the basis of region as follows
  • North America (U.S. Canada) Market size, Y-O-Y
    growth Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin
    America) Market size, Y-O-Y growth Opportunity
    Analysis
  • Europe (U.K., Germany, France, Italy, Spain,
    Hungary, Belgium, Netherlands Luxembourg, Rest
    of Europe) Market size, Y-O-Y growth
    Opportunity Analysis
  • Asia-Pacific (China, India, Japan, Singapore,
    Australia, New Zealand, South Korea Rest of
    Asia-Pacific) Market size, Y-O-Y growth
    Opportunity Analysis
  • Middle East and Africa (GCC, North Africa, South
    Africa Rest of Middle East and Africa) Market
    Size and Y-O-Y Growth Analysis
  • Growth Drivers Challenges
  • Rising number of HIV cases is expected to be one
    of the key growth drivers for anti-viral drugs
    market. Further, rising awareness about this
    deadly diseases are substantially raising the
    demand for the anti-viral drugs globally.
    According to WHO, the number of people infected
    with HIV were estimated to be 36.7 Million in
    2016. Additionally, 1.8 Million new cases of HIV
    were registered in 2016. This high growth in the
    number of HIV cases is believed to garner the
    growth of global anti-viral drugs market.
  • Furthermore, research development associated
    with the anti-viral drugs market is expected to
    drive the growth of the anti-viral drugs market
    globally. Apart from this, favorable government
    healthcare regulations are envisioned to bolster
    the growth of the global anti-viral drugs market.
    In contrast, high cost of advanced developing
    anti-viral drugs is anticipated to restrain the
    development of anti-viral drugs market. Further,
    lack of awareness about the viral diseases is
    expected to limit the growth of the global
    anti-aging market.

5
  • Key Players
  • GlaxoSmithKline PLC
  • Company Overview
  • Key Product Offerings
  • Business Strategy
  • SWOT Analysis
  • Financials
  • Johnson and Johnson
  • Merck Co
  • Abbott Laboratories
  • Cipla Limited
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers-Squibb
  • Gilead Sciences
  • Scope and Context
  • Overview of the Parent Market
  • Analyst View

6
Sample Research Presentation Look for
Your Requested Research/TOC
7
Our Services
Research Analysis
Actionable Insight
Business Solution
Data Analysis
Data Collection
Primary Research
Company Analysis
Secondary /Desk Research
We Offer In-depth Industry Analysis Our
exhaustive research reports are a combination of
qualitative and quantitative data and
analysis Research conducted using credible
database and industry tools and primary insights
Unbiased and detailed analysis of financial
statistics, competitors analysis Market size
estimation (by value and volume) and
forecasting Detailed mapping on SWOT Analysis,
Porters Five Force Model Analysis, PESTEL
Analysis Custom Research Services Tracking the
market as per the industrys movement Conducting
interviews to portray real situations and
industrys trends In-depth analysis and
information gathering as per clients
requirement Provide 360 degree approach reports
to meet clients specific requirement
Market Assessment /Estimation s/Forecast
Study of Developme nts
Future Share
Target Market
Competition Study
Channel Assessment
Recommendation
8
Entering New Emerging Markets
Launch Viability of Product
Competitive Analysis
Industry Analysis
Research Nester, currently serving clients from
120 countries clients across the globe, is a
leading service provider for strategic market
research and consulting. We aim to provide
unbiased, unparalleled market insights and
industry analysis to help industries,
conglomerates and executives to take wise
decisions for their future marketing strategy,
expansion and investment etc. We believe every
business can expand to its new horizon, provided
a right guidance at a right time is available
through strategic minds. Our out of box thinking
helps our clients to take wise decision so as to
avoid future uncertainties. Through our robust,
unbiased extensive primary and secondary
research, we help organizations to understand
current and future market trends, thus letting
them making a prolonged yet dynamic financial
investment.
9
Real Estate
Food Beverage
FMCG
Energy Power
Industries Catered
Copyright Research
Nester
www.researchnester.com
Healthcare
ICT
Semiconductor
Information Technology
10
To know more about please visit
https//www.researchnester.com/reports/anti-vira
l-drug-market-global-historical-growth-2012-2016-f
uture-outlook-2017-2024-demand-analysis-opportunit
y-evaluation/473 Related Reports https//www.re
searchnester.com/reports/medical-equipment-rental-
market-global-historical-growth-2012-2016-future-o
utlook-2017-2024-demand-analysis-opportunity-evalu
ation/495 https//www.researchnester.com/reports/
frictionless-remote-monitoring-device-market-globa
l-historical-growth-2012-2016-future-outlook-2017-
2024-demand-analysis-opportunity-evaluation/492
For More Info/Enquiry, Please Visit us
at Research Nester 1820 Avenue M, Suite 1113
Brooklyn, New York 11230 U.S. (T) 1 646 586
9123 Canada (T) 1 437 889 3230 U.K. (T) 44 203
608 5919 India (T) 91 120 660 5495 www.researchne
ster.com, info_at_researchnester.com
Thank You
About PowerShow.com